Milestone Pharmaceuticals (MIST) PT Lowered to $5 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Edward Tenthoff lowered the price target on Milestone Pharmaceuticals (NASDAQ: MIST) to $5.00 (from $6.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
